Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.
N Engl J Med. 2012 Feb 23;366(8):687-96. doi: 10.1056/NEJMoa1100370.
In the National Polyp Study (NPS), colorectal cancer was prevented by colonoscopic removal of adenomatous polyps. We evaluated the long-term effect of colonoscopic polypectomy in a study on mortality from colorectal cancer.
We included in this analysis all patients prospectively referred for initial colonoscopy (between 1980 and 1990) at NPS clinical centers who had polyps (adenomas and nonadenomas). The National Death Index was used to identify deaths and to determine the cause of death; follow-up time was as long as 23 years. Mortality from colorectal cancer among patients with adenomas removed was compared with the expected incidence-based mortality from colorectal cancer in the general population, as estimated from the Surveillance Epidemiology and End Results (SEER) Program, and with the observed mortality from colorectal cancer among patients with nonadenomatous polyps (internal control group).
Among 2602 patients who had adenomas removed during participation in the study, after a median of 15.8 years, 1246 patients had died from any cause and 12 had died from colorectal cancer. Given an estimated 25.4 expected deaths from colorectal cancer in the general population, the standardized incidence-based mortality ratio was 0.47 (95% confidence interval [CI], 0.26 to 0.80) with colonoscopic polypectomy, suggesting a 53% reduction in mortality. Mortality from colorectal cancer was similar among patients with adenomas and those with nonadenomatous polyps during the first 10 years after polypectomy (relative risk, 1.2; 95% CI, 0.1 to 10.6).
These findings support the hypothesis that colonoscopic removal of adenomatous polyps prevents death from colorectal cancer. (Funded by the National Cancer Institute and others.).
在全国息肉研究(NPS)中,通过结肠镜切除腺瘤性息肉来预防结直肠癌。我们评估了结直肠腺瘤息肉切除术对结直肠癌死亡率的长期影响。
我们纳入了这项分析中所有前瞻性接受 NPS 临床中心初次结肠镜检查(1980 年至 1990 年期间)并具有息肉(腺瘤和非腺瘤)的患者。国家死亡索引用于识别死亡并确定死亡原因;随访时间最长为 23 年。腺瘤切除患者的结直肠癌死亡率与一般人群中基于估计的结直肠癌发病率死亡率进行比较,这是根据监测、流行病学和最终结果(SEER)计划进行估计的,与非腺瘤性息肉患者的结直肠癌死亡率(内部对照组)进行比较。
在参与研究的 2602 例切除腺瘤的患者中,中位数随访 15.8 年后,有 1246 例患者死于任何原因,有 12 例死于结直肠癌。根据一般人群中估计的 25.4 例结直肠癌预期死亡,基于发病率的标准化死亡率比为 0.47(95%置信区间[CI],0.26 至 0.80),表明结直肠腺瘤息肉切除术可降低 53%的死亡率。在息肉切除后的前 10 年内,腺瘤患者与非腺瘤患者的结直肠癌死亡率相似(相对风险,1.2;95%CI,0.1 至 10.6)。
这些发现支持这样的假设,即结肠镜下切除腺瘤性息肉可预防结直肠癌死亡。(由美国国立癌症研究所等资助)。